Developer docs
API playgroundTry for free, no card

Search company profiles

Kx Advisors

Full company profile

uuid000ax8n

Namestring
Kx Advisors
Legal namestring
BGB Group
Websiteurl
kxadvisors.com
Company typeenum
Private
Founded yearint
1983
Descriptiontext

Kx Advisors is a boutique strategy consulting firm providing growth strategy advisory services exclusively to the healthcare industry. Founded in 1983 as the healthcare practice of Kaiser Associates and now operating as part of BGBx Consulting under the BGB Group umbrella, the firm serves pharmaceutical, biotechnology, medical device, diagnostics and life sciences, digital health and health IT, and private equity/investor clients across four offices (Washington DC headquarters, London, Boston, and New York). Its service portfolio spans Corporate Strategy and Franchise Planning, Market Expansion and Forecasting, Mergers and Acquisitions Advisory, New Product Planning, Pricing and Market Access, Brand Planning and Launch Strategy, and Commercial Due Diligence, delivered through senior-led, custom engagements.

The firm has no proprietary technology products; its core capability rests on consulting methodology, analytical frameworks, and primary research — drawing on a bench of PhD-holding consultants and alumni of McKinsey, BCG, IQVIA, Pfizer, and PwC with deep therapeutic-area specialization in oncology, immunology, neurology, rare diseases, and other areas. Kx also productizes thought leadership through recurring publications such as the annual Hot Indications List, Cell and Gene Therapy market analyses, and ASCO/AACR conference syntheses.

Revenue is generated through fee-for-service, engagement-based consulting with no publicly disclosed pricing. The go-to-market motion is direct and relationship-driven, targeting senior healthcare executives at enterprise pharma, biotech, and medical device companies, supplemented by thought-leadership content, industry conferences (ASCO, AACR, OSET, AACC, World Orphan Drug Congress), and partnerships such as its 2023 alliance with HealthTech Arkansas. The firm holds SOC 2 Type 2 compliance and has been recognized in the Vault Consulting 50 (2022, 2023) and through Consulting Magazine awards for individual practitioners.

Short descriptiontext

Kx Advisors is a boutique healthcare strategy consulting firm, founded in 1983 and now part of BGBx Consulting, serving pharmaceutical, biotech, medical device, diagnostics, digital health, and private equity clients across the US, UK, and EMEA with growth strategy, M&A, and commercial due diligence advisory services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersWashington, United States
HQ citystring
Washington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare strategy consulting, pharmaceutical growth strategy, biotech advisory services, medical device consulting, commercial due diligence
Industry2 codes
PRIMARYBPAHAOAE
Equity Capital Advisory (Private Equity Placements, Growth Capital)
SECONDARYBPAHAEAC
Customer Experience (CX) & Digital Experience
NAICS code2 codes
  • Management Consulting Services54161
  • Management, Scientific, and Technical Consulting Services5416
SIC code2 codes
  • Services-Management Consulting Services8742
  • Services-Engineering, Accounting, Research, Management8700
Product category
Healthcare Strategy Consulting
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Strategy Consulting Services
TypeProfessional Services
Description

Kx Advisors generates revenue through fee-for-service consulting engagements. They provide growth strategy consulting to healthcare companies, including corporate strategy, market expansion, M&A advisory, new product planning, pricing and market access, and brand planning services. Revenue is project-based and likely varies by engagement scope, duration, and team size assigned.

kxadvisors.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Custom engagement-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Consulting fees are determined based on project scope, team size, expertise required, and deliverables. No public pricing is available as engagements are custom-tailored to client needs.

kxadvisors.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Kx Advisors is a boutique healthcare strategy consulting firm that delivers growth strategy advisory services to pharmaceutical, biotechnology, medical device, diagnostics and life sciences, digital health, and health IT companies, as well as healthcare-focused private equity investors. Its core offerings span six practice capabilities: Corporate Strategy and Franchise Planning, Market Expansion and Forecasting, Mergers and Acquisitions Advisory, New Product Planning, Pricing and Market Access, and Brand Planning and Launch Strategy, delivered through project-based engagements priced by scope and team composition.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Clients report high satisfaction with analytical rigor, business understanding, and actionable recommendations
+2 more records
Product overview1 text field

Kx Advisors is a healthcare strategy consulting firm (operating as Kaiser Associates' healthcare practice) offering a portfolio of advisory services including Corporate Strategy and Franchise Planning, Market Expansion and Forecasting, Mergers and Acquisitions Advisory, New Product Planning, Pricing and Market Access, Brand Planning and Launch Strategy, and Commercial Due Diligence. The firm supports clients across five sectors: Pharma and Biotech, Medical Devices, Diagnostics and Life Sciences, Digital Health and Health IT, and Investors. Beyond consulting services, Kx produces proprietary research publications including the annual Hot Indications List, Cell and Gene Therapy market analyses, and Oncology conference insights from ASCO and AACR.

Product and service1 record
1Corporate Strategy and Franchise Planning
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-02-08
Description

Kx Advisors partnered with HealthTech Arkansas to provide growth strategy consulting services to biotherapeutics startup companies participating in the BioAR Trial accelerator program. Kx provides advisory services to help these companies capitalize on product opportunities and develop growth strategies.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global strategy consulting firm with a strong healthcare and life sciences practice. Kx and L.E.K. compete directly for healthcare growth strategy, M&A advisory, and commercial due diligence engagements; a former Kx partner previously worked at L.E.K.

TypeDirect peer
Description

Boutique healthcare strategy consulting firm (now part of Parexel) focused on medtech, biopharma, and diagnostics. Closely comparable in size, therapeutic-area depth, and service offering; a Kx SVP previously led the MSK practice at Health Advances.

TypeDirect peer
Description

Life sciences-focused commercial strategy and insights firm serving pharma and biotech. Overlaps with Kx on brand planning, launch strategy, and commercial diligence; a Kx SVP previously worked at Trinity Life Sciences.

4ZS Associates
TypeDirect peer
Description

Large global consulting firm specializing in healthcare and pharma sales, marketing, and strategy. Directly competes with Kx on pharma growth strategy, launch planning, and commercial execution engagements.

TypeBroad incumbent
Description

Global life sciences and healthcare data/consulting powerhouse. A former Kx partner led life sciences commercial strategy engagements at IQVIA; significant overlap on pharma commercial launch strategy and analytics.

TypeBroad incumbent
Description

Global strategy consulting arm of PwC with a substantial healthcare practice. A Kx partner previously led life sciences engagements at Strategy&; competes for healthcare growth strategy and transformation work at large enterprises.

TypeBroad incumbent
Description

Premier global management consulting firm with a large healthcare practice. A Kx VP previously worked at McKinsey; competes on the largest healthcare strategy engagements though typically at much higher price points.

TypeBroad incumbent
Description

Top-tier global consulting firm with deep healthcare and life sciences expertise. A Kx VP previously worked at BCG; directly competes for enterprise-level pharma and medtech growth strategy work.

TypeBroad incumbent
Description

Global consulting firm with significant life sciences practice offering commercial due diligence, M&A advisory, and strategy work for healthcare investors and corporates. Highly comparable on PE-focused CDD engagements.

TypeDirect peer
Description

Boutique healthcare strategy consulting firm serving biopharma clients on commercial strategy, market access, and pricing. Similar size and specialization to Kx with comparable service offerings in pharma and biotech.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles19 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Kx Advisors

Healthcare Strategy Consultingkxadvisors.com

Kx Advisors is a boutique healthcare strategy consulting firm, founded in 1983 and now part of BGBx Consulting, serving pharmaceutical, biotech, medical device, diagnostics, digital health, and private equity clients across the US, UK, and EMEA with growth strategy, M&A, and commercial due diligence advisory services.

What Kx Advisors does

Kx Advisors is a boutique strategy consulting firm providing growth strategy advisory services exclusively to the healthcare industry. Founded in 1983 as the healthcare practice of Kaiser Associates and now operating as part of BGBx Consulting under the BGB Group umbrella, the firm serves pharmaceutical, biotechnology, medical device, diagnostics and life sciences, digital health and health IT, and private equity/investor clients across four offices (Washington DC headquarters, London, Boston, and New York). Its service portfolio spans Corporate Strategy and Franchise Planning, Market Expansion and Forecasting, Mergers and Acquisitions Advisory, New Product Planning, Pricing and Market Access, Brand Planning and Launch Strategy, and Commercial Due Diligence, delivered through senior-led, custom engagements.

The firm has no proprietary technology products; its core capability rests on consulting methodology, analytical frameworks, and primary research — drawing on a bench of PhD-holding consultants and alumni of McKinsey, BCG, IQVIA, Pfizer, and PwC with deep therapeutic-area specialization in oncology, immunology, neurology, rare diseases, and other areas. Kx also productizes thought leadership through recurring publications such as the annual Hot Indications List, Cell and Gene Therapy market analyses, and ASCO/AACR conference syntheses.

Revenue is generated through fee-for-service, engagement-based consulting with no publicly disclosed pricing. The go-to-market motion is direct and relationship-driven, targeting senior healthcare executives at enterprise pharma, biotech, and medical device companies, supplemented by thought-leadership content, industry conferences (ASCO, AACR, OSET, AACC, World Orphan Drug Congress), and partnerships such as its 2023 alliance with HealthTech Arkansas. The firm holds SOC 2 Type 2 compliance and has been recognized in the Vault Consulting 50 (2022, 2023) and through Consulting Magazine awards for individual practitioners.

Kx Advisors firmographics

Firmographics
Name
Kx Advisors
Legal name
BGB Group
Website
https://kxadvisors.com
Company type
Private
Founded year
1983
Operating status
Operating
Headcount range
51–100 employees
Short description
Kx Advisors is a boutique healthcare strategy consulting firm, founded in 1983 and now part of BGBx Consulting, serving pharmaceutical, biotech, medical device, diagnostics, digital health, and private equity clients across the US, UK, and EMEA with growth strategy, M&A, and commercial due diligence advisory services.
Ownership category
akta.pro rank

Kx Advisors industry classification

Industry
Product category
Healthcare Strategy Consulting
NAICS
Management Consulting Services (54161), Management, Scientific, and Technical Consulting Services (5416)
SIC
Services-Management Consulting Services (8742), Services-Engineering, Accounting, Research, Management (8700)
akta.pro industry
PRIMARYBPAHAOAE
Equity Capital Advisory (Private Equity Placements, Growth Capital)
SECONDARYBPAHAEAC
Customer Experience (CX) & Digital Experience

Keywords

  • Healthcare strategy consulting
  • Pharmaceutical growth strategy
  • Biotech advisory services
  • Medical device consulting
  • Commercial due diligence

Where Kx Advisors is headquartered

Location

Headquarters

HQ city
Washington
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Kx Advisors business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Strategy Consulting Services: Kx Advisors generates revenue through fee-for-service consulting engagements. They provide growth strategy consulting to healthcare companies, including corporate strategy, market expansion, M&A advisory, new product planning, pricing and market access, and brand planning services. Revenue is project-based and likely varies by engagement scope, duration, and team size assigned.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom engagement-based pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Kx Advisors product offering

Product offering

Core offering

Kx Advisors is a boutique healthcare strategy consulting firm that delivers growth strategy advisory services to pharmaceutical, biotechnology, medical device, diagnostics and life sciences, digital health, and health IT companies, as well as healthcare-focused private equity investors. Its core offerings span six practice capabilities: Corporate Strategy and Franchise Planning, Market Expansion and Forecasting, Mergers and Acquisitions Advisory, New Product Planning, Pricing and Market Access, and Brand Planning and Launch Strategy, delivered through project-based engagements priced by scope and team composition.

Product overview

Kx Advisors is a healthcare strategy consulting firm (operating as Kaiser Associates' healthcare practice) offering a portfolio of advisory services including Corporate Strategy and Franchise Planning, Market Expansion and Forecasting, Mergers and Acquisitions Advisory, New Product Planning, Pricing and Market Access, Brand Planning and Launch Strategy, and Commercial Due Diligence. The firm supports clients across five sectors: Pharma and Biotech, Medical Devices, Diagnostics and Life Sciences, Digital Health and Health IT, and Investors. Beyond consulting services, Kx produces proprietary research publications including the annual Hot Indications List, Cell and Gene Therapy market analyses, and Oncology conference insights from ASCO and AACR.

Differentiator

Problem solved

Functional benefit

Products and services

  • Corporate Strategy and Franchise Planning

Quantifiable outcome

  • Clients report high satisfaction with analytical rigor, business understanding, and actionable recommendations
  • +2 more outcomes

Companies that use Kx Advisors

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Kx Advisors technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Kx Advisors partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • HealthTech ArkansasminorStrategic or Co-development Partner · 8 February 2023Kx Advisors partnered with HealthTech Arkansas to provide growth strategy consulting services to biotherapeutics startup companies participating in the BioAR Trial accelerator program. Kx provides advisory services to help these companies capitalize on product opportunities and develop growth strategies.

Scale indicators2 records

Recent moves8 records

Expansion highlights6 records

Kx Advisors competitors and assessment

Company assessment

Direct peers

  • L.E.K. Consulting: Global strategy consulting firm with a strong healthcare and life sciences practice. Kx and L.E.K. compete directly for healthcare growth strategy, M&A advisory, and commercial due diligence engagements; a former Kx partner previously worked at L.E.K.
  • Health Advances: Boutique healthcare strategy consulting firm (now part of Parexel) focused on medtech, biopharma, and diagnostics. Closely comparable in size, therapeutic-area depth, and service offering; a Kx SVP previously led the MSK practice at Health Advances.
  • Trinity Life Sciences: Life sciences-focused commercial strategy and insights firm serving pharma and biotech. Overlaps with Kx on brand planning, launch strategy, and commercial diligence; a Kx SVP previously worked at Trinity Life Sciences.
  • ZS Associates: Large global consulting firm specializing in healthcare and pharma sales, marketing, and strategy. Directly competes with Kx on pharma growth strategy, launch planning, and commercial execution engagements.
  • Putnam Associates: Boutique healthcare strategy consulting firm serving biopharma clients on commercial strategy, market access, and pricing. Similar size and specialization to Kx with comparable service offerings in pharma and biotech.

Broad incumbents

  • IQVIA: Global life sciences and healthcare data/consulting powerhouse. A former Kx partner led life sciences commercial strategy engagements at IQVIA; significant overlap on pharma commercial launch strategy and analytics.
  • Strategy& (PwC): Global strategy consulting arm of PwC with a substantial healthcare practice. A Kx partner previously led life sciences engagements at Strategy&; competes for healthcare growth strategy and transformation work at large enterprises.
  • McKinsey & Company: Premier global management consulting firm with a large healthcare practice. A Kx VP previously worked at McKinsey; competes on the largest healthcare strategy engagements though typically at much higher price points.
  • Boston Consulting Group: Top-tier global consulting firm with deep healthcare and life sciences expertise. A Kx VP previously worked at BCG; directly competes for enterprise-level pharma and medtech growth strategy work.
  • Charles River Associates: Global consulting firm with significant life sciences practice offering commercial due diligence, M&A advisory, and strategy work for healthcare investors and corporates. Highly comparable on PE-focused CDD engagements.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Kx Advisors social profiles

Digital presence

Kx Advisors compliance and trust

Trust signal

Compliance1 record

Kx Advisors financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kx Advisors leadership team

Management profile

Number of profiles

Profiles19 records

Kx Advisors funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kx Advisors M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kx Advisors

What does Kx Advisors do?

Kx Advisors is a boutique healthcare strategy consulting firm that delivers growth strategy advisory services to pharmaceutical, biotechnology, medical device, diagnostics and life sciences, digital health, and health IT companies, as well as healthcare-focused private equity investors. Its core offerings span six practice capabilities: Corporate Strategy and Franchise Planning, Market Expansion and Forecasting, Mergers and Acquisitions Advisory, New Product Planning, Pricing and Market Access, and Brand Planning and Launch Strategy, delivered through project-based engagements priced by scope and team composition.

Is Kx Advisors a public or private company?

Kx Advisors is a private company. It is classified as corporate owned and is currently operating.

When was Kx Advisors founded?

Kx Advisors was founded in 1983. It employs 51 to 100 people.

Where is Kx Advisors based?

Kx Advisors is headquartered in Washington, United States, in the North America region.

How does Kx Advisors make money?

One revenue line is on record: strategy Consulting Services.

Who are Kx Advisors's main competitors?

Direct peers on record are L.E.K. Consulting, Health Advances, Trinity Life Sciences, ZS Associates and Putnam Associates. Broad incumbents are IQVIA, Strategy& (PwC), McKinsey & Company, Boston Consulting Group and Charles River Associates.

Does Kx Advisors have an API?

No public API is recorded for Kx Advisors.

What industry is Kx Advisors in?

Kx Advisors's product category is Healthcare Strategy Consulting. Its primary akta.pro industry code is BPAHAOAE, Equity Capital Advisory (Private Equity Placements, Growth Capital), with a secondary code of BPAHAEAC, Customer Experience (CX) & Digital Experience. Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Kxadvisorsneurodiagnostics ArchivesThe provided text consists of multiple distinct industry reports and conference recaps from Kx Advisors covering ASCO 2025, AACR 2025, AI in neurodiagnostics, and the OSET 2024 orthopedic summit. These sections analyze strategic trends in oncology innovation, the regulatory landscape for Alzheimer's imaging software, and networking developments in orthopedics. The content functions as a composite feed of professional insights rather than a single cohesive news event.Business Wire BlogBGB Group Acquires Healthcare Consultancy Kx AdvisorsBGB Group, a healthcare communications company based in New York City, has acquired Kx Advisors, a leading healthcare strategy consultancy with offices in Washington D.C., London, and Boston. This acquisition is part of BGB’s ongoing capability expansion to enhance its strategic consulting services for clients across the commercial lifecycle. The financial terms of the transaction were not disclosed.BgbgroupPress ReleasesBGB Group announced the acquisition of healthcare strategy consultancy Kx Advisors on September 13, 2023. This transaction is part of BGB's ongoing capability expansion to enhance its strategic consulting offerings for pharma clients. The financial terms of the deal were not disclosed.KxadvisorsFor Patient Engagement solutions looking for an exit, 2023 could be their yearKx Advisors surveyed over 350 attendees at HLTH Conference 2022 and found that more than 83% of digital health leaders expect their organizations to complete at least one acquisition in 2023. Patient Engagement and Digital Front Door solutions ranked as the top priority for 80% of respondents, with Screening, Monitoring and Diagnostics next. Kx projects deal volume may rebound moderately while average deal size shrinks.Talk Business & PoliticsHealthTech Arkansas, Kx Advisors partner to help biotherapeutics startups - Talk Business & PoliticsHealthTech Arkansas and Kx Advisors announced a partnership to support biotherapeutics startups in the BioAR Trial accelerator program. The partnership includes a virtual seminar on growth strategies and one-on-one follow-up sessions. Applications for BioAR Trial are open through February 28, 2023.PR NewswireHealthTech Arkansas and Kx Advisors Partner to Provide Growth Strategy Services to the Bioar Trial Accelerator ParticipantsHealthTech Arkansas and Kx Advisors partnered to provide growth strategy services to biotherapeutics startups in the BioAR Trial accelerator program. The partnership includes a virtual seminar and one-on-one follow-up sessions for cohort companies. Applications for BioAR Trial are open through February 28, 2023.PR NewswireKaiser Associates' Healthcare Practice is Now Kx AdvisorsKaiser Associates announced the launch of Kx Advisors, a healthcare strategy consultancy operating as a rebranded version of its existing Healthcare Practice, effective immediately. The new entity will be co-led by Dan O'Neill and Bob Serrano and operates from Washington D.C., London, and Hong Kong offices. Kx Advisors plans to add additional headcount and expand its data assets and reporting capabilities, while Kaiser Associates will continue to serve clients across six other practice areas.NewswireKaiser Associates' Healthcare Practice is Now Kx AdvisorsKaiser Associates launched Kx Advisors, its healthcare strategy consultancy, co-led by Dan O'Neill and Bob Serrano. The team will continue delivering data-driven growth strategy for clients in pharma, biotech, medical device, and health IT, with plans to add headcount and invest in data assets.